Fuat KIZILAY, Mustafa Serdar KALEMCİ, Adnan ŞİMŞİR, Burak TURNA, Oktay NAZLI, Afig BERDELİ

6644

The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype–phenotype relationship

To determine the relationship between androgen receptor (AR) gene polymorphism and prostate cancer in our society. Materials and methods: Thirty-nine patients diagnosed with prostate cancer and 34 benign prostatic hyperplasia (BPH) patients who were diagnosed in 2010 met the study criteria. The inclusion criteria included patients whose diagnosis was confirmed with a biopsy, with the presence of adequate pathologic material for review, between the ages of 40 and 80, and who were healthy men without a family history of prostate cancer. The exclusion criteria excluded men diagnosed with another cancer and those who had kin with a history of prostate cancer. A direct DNA sequencing method was utilized for detection of polymorphisms. Results: CAG repeat length varied from 13 to 28 (mean: 21.67) for the BPH group and 12 to 28 (mean: 21.74) for the prostate cancer group. Prostate-specific antigen (PSA) density and the androgen receptor (AR) CAG repeat had a statistically significant negative correlation in the BPH group. A statistically significant difference was associated between AR CAG repeat and PSA density. Conclusion: Randomized prospective studies should be planned with larger patient and control groups and with more variables, which may open new horizons in prostate cancer screening and early detection.
Anahtar Kelimeler:

Key words: Androgen receptor, mutation, polymorphism, prostatic hyperplasia, prostatic neoplasm

The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype–phenotype relationship

To determine the relationship between androgen receptor (AR) gene polymorphism and prostate cancer in our society. Materials and methods: Thirty-nine patients diagnosed with prostate cancer and 34 benign prostatic hyperplasia (BPH) patients who were diagnosed in 2010 met the study criteria. The inclusion criteria included patients whose diagnosis was confirmed with a biopsy, with the presence of adequate pathologic material for review, between the ages of 40 and 80, and who were healthy men without a family history of prostate cancer. The exclusion criteria excluded men diagnosed with another cancer and those who had kin with a history of prostate cancer. A direct DNA sequencing method was utilized for detection of polymorphisms. Results: CAG repeat length varied from 13 to 28 (mean: 21.67) for the BPH group and 12 to 28 (mean: 21.74) for the prostate cancer group. Prostate-specific antigen (PSA) density and the androgen receptor (AR) CAG repeat had a statistically significant negative correlation in the BPH group. A statistically significant difference was associated between AR CAG repeat and PSA density. Conclusion: Randomized prospective studies should be planned with larger patient and control groups and with more variables, which may open new horizons in prostate cancer screening and early detection.
Keywords:

Key words: Androgen receptor, mutation, polymorphism, prostatic hyperplasia, prostatic neoplasm,

PDF

___

  • Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 2000; 92: 2009–2017.
  • Bratt O,  Borg A,  Kristoffersson U,  Lundgren R,  Zhang QX, Olsson H. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Br J Cancer 1999; 81: 672–676.
  • Eeles RA, Edwards SM, Minter R. Androgen receptor polymorphisms: their association with prostate cancer risk, relapse and overall survival. Programs and abstracts of the 1998 Annual Meeting of the American Society of Human Genetics. Am J Hum Genet 1998; 4: A21.
  • Chamberlain NC, Driver ED, Mielsfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucl Acid Res 1994; 22: 3181–3186.
  • Kufe DW, Pollack RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E, editors. Cancer Medicine. 6th ed. Hamilton, ON, Canada: B.C. Decker; 2003..
  • Sawaya ME, Shalita AR. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 1998; 3: 9–15.
  • Balic I,  Graham ST,  Troyer DA,  Higgins BA,  Pollock BH,  Johnson-Pais TL,  Thompson IM,  Leach RJ. Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. J Urol 2002: 168: 2245–2248.
  • Mononen N,  Ikonen T,  Autio V,  Rökman A,  Matikainen MP, Tammela TL, Kallioniemi OP, Koivisto PA, Schleutker J. Androgen receptor CAG polymorphism and prostate cancer risk. Hum Genet 2002; 111: 166–171.
  • Coughlin SS, Hall IJ. A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol 2002; 12: 182–196.
  • Nelson KA,  Witte JS. Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol 2002; 155: 883–890.
  • Lai CL, L’Eplattenier H, van den Ham R, Verseijden F, Jagtenberg A, Mol JA, Teske E. Androgen receptor CAG repeat polymorphisms in canine prostate cancer. J Vet Intern Med 2008; 22: 1380–1384.
  • Latil AG,  Azzouzi R,  Cancel GS,  Guillaume EC,  Cochan- Priollet B,  Berthon PL,  Cussenot O. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer 2001; 92: 1130–1137.
  • Bousema JT, Bussemakers MJ, van Houwelingen KP, Debruyne FM, Verbeek AL, de La Rosette JJ. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol 2000; 37: 234–238.
  • Salinas CA, Austin MA, Ostrander EO, Stanford JL. Polymorphisms in the androgen receptor and the prostate- specific antigen genes and prostate cancer risk. Prostate 2005; 65: 58–65.
  • Jesser C, Mucci L, Farmer D, Moon C, Li H, Gaziano JM. Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels. Br J Cancer 2008; 99: 1743–1747.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Comparison of different ligation techniques in laparoscopic varicocelectomy*

Işıl BAŞARA, Aliseydi BOZKURT, Mutlu ATEŞ, Yiğit AKIN, Barış NUHOĞLU, Selçuk YÜCEL, Orçun ÇELİK

Clinical manifestations, complications, and treatment of brucellosis: evaluation of 72 cases

Şükran KÖSE, Süheyla Serin SENGER, Gülgün AKKOÇLU, Lütfiye KUZUCU

MEFV mutation frequency and effect on disease severity in ankylosing spondylitis

Yüksel MARAŞ, Ali AKDOĞAN, Bünyamin KISACIK, Levent KILIÇ, Engin YILMAZ, Abdurrahman TUFAN, Umut KALYONCU, Şaziye Şule APRAŞ BİLGEN, Sedat KİRAZ, Ali İhsan ERTENLİ, Meral ÇALGÜNERİ

Comparison of disc and body volumes in degenerated and nondegenerated lumbar discs: a stereological study

Tuncay KANER, Ahmet SONGUR, Muhsin TOKTAŞ, Ozan Alper ALKOÇ, Olcay ESER, Mustafa EFENDİOĞLU

Evaluation of hepatocellular carcinoma with computed tomography perfusion imaging

Ümmügülsüm BAYRAKTUTAN, Abdulmecit KANTARCI, Hayri OĞUL, Yeşim KIZRAK, Ömer ÖZYİĞİT, Zeyneb YÜCELER, Berhan GENÇ, Bünyami ÖZOĞUL

Expression of NADPH-d in the vagal nuclei of the chronic esophagitis model in rats

Ümit Süleyman ŞEHİRLİ, Halil TUĞTEPE, Ural VERİMLİ, Özlem KİRAZLI, Mazhar ÖZKAN, Emrullah Tolga DAĞLI

Comparing the fatty acid levels of preterm and term breast milk in Turkish women

İbrahim AYDIN, Özden TURAN, Fevzi Nuri AYDIN, Esin KOÇ, İbrahim Murat HİRFANOĞLU, Mesut AKYOL, Muzaffer ÖZTOSUN, Emin Özgür AKGÜL, Hilmi DEMİRİN, Selim KILIÇ, Mehmet Kemal ERBİL, Taner ÖZGÜRTAŞ

Comparison of different ligation techniques in laparoscopic varicocelectomy

Yiğit AKIN, Mutlu ATEŞ, Selçuk YÜCEL, İşıl BAŞARA, Orçun ÇELİK, Aliseydi BOZKURT, Barış NUHOĞLU

Investigation of the effects of magnetic field exposure on febrile seizure latency, seizure duration, and electroencephalographic recordings in a rat febrile convulsion model

Tuncer DEMİR, Sefa GÜLTÜRK, Ayşe Demirkazik ÇANÇALAR, Nedim DURMUŞ

Intrathoracic Castleman disease

Pınar BIÇAKÇIOĞLU, Selim Şakir Erkmen GÜLHAN, Leyla Nesrin ACAR, Yetkin AĞAÇKIRAN, Şeref ÖZKARA, Sadi KAYA, Nurettin KARAOĞLANOĞLU